molecule01
molecule02
molecule04
molecule05
molecule06
molecule07
molecule09
molecule08
molecule10
logo-symbol

From Topology to Treatments

Congruence Therapeutics is a drug discovery company that is uniquely harnessing the power of innovative fields such as protein dynamics, biophysics, machine learning and computational chemistry. Our ground-breaking discovery engine, Revenir™, sees proteins in ways others have been unable to see - in their full dynamic state.

background-careers

We’re building a world-class team of drug hunters to efficiently design small molecules for diseases with high unmet medical need.

Drug hunters apply here

background-news

Congruence closes Series A funding round

The US$50M Series A financing was led by Amplitude Ventures and Fonds de solidarité FTQ, with participation from Lumira Ventures, Investissement Quebec, OrbiMed Advisors, Driehaus and others.

Need to reach us?

If you are interested in a Chemistry position and want to learn more, contact Lee Fader Ph.D., Vice President Chemistry.

Need to reach us?

If you are interested in a Chemistry position and want to learn more, contact Lee Fader Ph.D., Vice President Chemistry.

    *Required Fields